Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It focuses on depression.
In The BronxThis study has public registry information. It focuses on anxiety and currently lists study information in the United States.
In New York
This study is completed. It focuses on ADHD and currently lists study information in Israel.
In HaifaThis study is completed. It focuses on ADHD and currently lists study information in the United States.
In StanfordThis study is completed. It focuses on PTSD and currently lists study information in the United States.
Multiple locations, including San Francisco
This study is completed. It focuses on ADHD and currently lists study information in Israel.
In HaifaThis study is completed. It focuses on ADHD and currently lists study information in the United States.
In Seattle
This study has public registry information. It focuses on bipolarity and currently lists study information in the United States.
In New YorkThis study has public registry information. It focuses on schizophrenia and currently lists study information in the United States.
Multiple locations, including San FranciscoThis study is ongoing in Spain. It is testing bifeprunox for Schizophrenia.
In SpainThis study is completed. It focuses on schizophrenia and currently lists study information in Japan.
In Sakai
This study is completed. It focuses on depression and currently lists study information in the United States.
In RochesterHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.